EGFR gene copy number as a prognostic marker in colorectal cancer patients treated with cetuximab or panitumumab: a systematic review and meta analysis
about
Markers of resistance to anti-EGFR therapy in colorectal cancerBiomarkers predicting resistance to epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer with wild-type KRASImmunotherapy for colorectal cancerColorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology ApproachRHBDD1 upregulates EGFR via the AP-1 pathway in colorectal cancer.Genetic and immune factors underlying the efficacy of cetuximab and panitumumab in the treatment of patients with metastatic colorectal cancer.Polymorphisms in Genes Involved in EGFR Turnover Are Predictive for Cetuximab Efficacy in Colorectal Cancer.Prognostic impact of KRAS mutant type and MET amplification in metastatic and recurrent gastric cancer patients treated with first-line S-1 plus cisplatin chemotherapy.Blood-based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer.Targeting tyrosine-kinases in ovarian cancer.Epidermal growth factor receptor: an important target in esophageal cancer.Strategies to overcome resistance to epidermal growth factor receptor monoclonal antibody therapy in metastatic colorectal cancer.MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer.EGFR inhibitors and autophagy in cancer treatment.Prognostic and Predictive Biomarkers in Colorectal Cancer: Implications for the Clinical Surgeon.GAGE12 mediates human gastric carcinoma growth and metastasis.Activation of proteinase-activated receptor 2 prevents apoptosis of lung cancer cells.Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.Impact of epidermal growth factor receptor protein and gene alteration on Taiwanese hepatocellular carcinomas.Gene copy number gain of EGFR is a poor prognostic biomarker in gastric cancer: evaluation of 855 patients with bright-field dual in situ hybridization (DISH) method.Integrating anti-EGFR therapies in metastatic colorectal cancer.Molecular-Targeted Therapies for Epidermal Growth Factor Receptor and Its Resistance Mechanisms.Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR.Molecular Biomarkers for the Evaluation of Colorectal Cancer.Clinical Pharmacokinetics and Pharmacodynamics of the Epidermal Growth Factor Receptor Inhibitor Panitumumab in the Treatment of Colorectal Cancer.
P2860
Q24598640-5B3F39A0-1363-4495-96AD-D1FEFCDBA0B7Q26766535-30124576-4C83-4C0C-BCCA-333FDCF9E338Q27021837-FAA5F3A2-EA4B-4F3A-BF86-6C857344F960Q28647615-B808CF0C-1AD9-49F6-BC46-CB07764A740AQ33648830-0E584DF5-3164-4F1F-9879-C7B751F0850FQ33683680-FA6EE545-FD90-47E6-95C4-EC0B8F54889DQ36132737-D287E9E7-ABB4-44F6-A8CD-298C5F345405Q36638061-03272B09-A7E5-4225-AFFB-70C2807E322BQ37321131-2D8570DB-9BAD-461A-9F7B-3CA28E21E966Q37697540-8D644020-B880-4ADE-8E78-E11C52A63C84Q38118388-DF4386BD-4749-41D1-9B7C-302011947484Q38121640-03D5CBFF-C7FB-48E8-9B65-F60AAC1A83E7Q38238743-0F48DBBA-4C3F-4690-B73F-C942EAE36B2FQ38247982-9B2FD25C-77E8-4D53-9436-55F3BFAB075BQ38257898-DEB4E03C-FD93-482A-82C0-CD3E13F6F61DQ38555225-A6099695-8D4E-4C65-BC92-83D92812D8BCQ38945005-8846375A-C433-4F71-B317-BD165F5C01DDQ39077024-8C4D35D2-B57A-4358-BC04-2620621DE8DEQ40341349-4A59CDEE-60B4-46AD-AF80-2BB18D2EC537Q41434771-484A8C52-C649-433A-A9F5-0987AADE0F6AQ41714879-E87325E4-677E-4596-9012-5AA67171032EQ43090496-8F28F2F3-B75C-40B2-BD3B-D8C2BC24F1A8Q47130146-25E3BB15-B642-430C-A0F4-7727AA613B2AQ48203761-5FA321E6-C921-4D1D-8905-D8014A59E108Q52794464-E1297B65-AE91-4177-B243-4D90DBB97B90Q55003485-C0992833-AC7F-4B7B-ABCC-2B184A328CEF
P2860
EGFR gene copy number as a prognostic marker in colorectal cancer patients treated with cetuximab or panitumumab: a systematic review and meta analysis
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
EGFR gene copy number as a pro ...... matic review and meta analysis
@ast
EGFR gene copy number as a pro ...... matic review and meta analysis
@en
EGFR gene copy number as a pro ...... matic review and meta analysis
@nl
type
label
EGFR gene copy number as a pro ...... matic review and meta analysis
@ast
EGFR gene copy number as a pro ...... matic review and meta analysis
@en
EGFR gene copy number as a pro ...... matic review and meta analysis
@nl
prefLabel
EGFR gene copy number as a pro ...... matic review and meta analysis
@ast
EGFR gene copy number as a pro ...... matic review and meta analysis
@en
EGFR gene copy number as a pro ...... matic review and meta analysis
@nl
P2093
P2860
P31
P921
P3181
P1433
P1476
EGFR gene copy number as a pro ...... matic review and meta analysis
@en
P2093
Chunxiang Li
Xishan Wang
Zheng Jiang
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0056205
P407
P5008
P577
2013-01-01T00:00:00Z
2013-02-18T00:00:00Z